Business

Glenmark Pharma to use USD40 mn loan for debt refinance, capex

Pharma major Glenmark Pharmaceuticals Ltd will be utilising the $40 million loan from International Finance Corporation (IFC) to refinance existing debt and for capital expenditure.

migrator

Chennai

Glenmark is having a good presence in generics, over the counter and specialty drugs. The IFC has committed an unsecured loan of $40 million to the company.

Queried about the deployment of the loan fund a company spokesperson told IANS: “The $40 mn loan will be utilized to refinance existing Foreign Currency Convertible Bonds (FCCBs) and capex funding.”

The IFC in 2016 had invested in convertible debt of $75 million in Glenmark for expansion project.

According to the Glenmark spokesperson, IFC had subscribed to the company’s FCCB for a principal of $75 million.

“The FCCB’s have maturity in June 2022 and are not yet converted,” the official said.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Iran security chief Larijani, Basij head killed in airstrikes, claims Israel

Latest: Israel says it killed top Iranian security official, Basij force chief

China to provide humanitarian aid to Iran, Lebanon, other West Asian nations

No way! ‘Thala’ Dhoni changes jersey number to 8

AIADMK MP stokes controversy, refers to leading female actor while criticising TN CM